Furthermore, the disruption of metabolic and inflammatory states can lead to reduced insulin tolerance and hyperinsulinemia, which then directly stimulate cell growth by binding on target cells like the pancreatic tissue. The gene discussed is INS; the disease is hyperinsulinism.